Work

A phase I trial of bexarotene, a retinoid X receptor agonist, in relapsed or refractory non-M3 acute myeloid leukemia (AML)

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.6567

Authors: D. E. Tsai, S. M. Luger, A. W. Loren, A. Kemner, J. Thompson, S. J. Schuster, A. Perl, D. L. Porter, A. Bagg, M. Carroll

Institution: University of Pennsylvania

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2249157200

Cites:

Cited by: 1

Related to: 10